BANK OF MONTREAL /CAN/ - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$23,000
-41.0%
20,029
+0.1%
0.00%–
Q1 2019$39,000
-17.0%
20,000
-1.4%
0.00%–
Q4 2018$47,000
-65.9%
20,293
+0.8%
0.00%–
Q3 2018$138,000
+4500.0%
20,128
+15264.9%
0.00%–
Q2 2018$3,000–131–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders